Check Cap

Check Cap EBITDA per Share

The EBITDA per Share of Check Cap (MBAI) as of Oct 9, 2026 is -2.67 USD. In the previous year, EBITDA per Share was -4.41 USD — a change of -39.53% (higher).

EBITDA per Share

-2.67USD

YoY

-39.53%

Last updated:

EBITDA per Share of Check Cap is 2025 -2.67 USD. EBITDA per Share of Check Cap was 2024 -4.41 USD. It decreases by -39.53% higher compared to the previous year.

The Check Cap EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
-4.33 USD
Jan 1, 2022
-3.27 USD
Jan 1, 2023
-3.18 USD
Jan 1, 2024
-4.41 USD
Jan 1, 2025
-2.67 USD
The Check Cap EBITDA per Share history
YEAREBITDA per ShareYoY
-2.67USD-39.53%
-4.41USD+38.62%
-3.18USD-2.81%
-3.27USD-24.45%
-4.33USD—
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

EBITDA per Share of Check Cap is -2.67 USD in 2025.

EBITDA per Share of Check Cap changed from -4.41 USD to -2.67 USD, representing a -39.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Check Cap since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Check Cap

All Key Metrics — Check Cap